65 related articles for article (PubMed ID: 21559684)
1. Analysis of the C-myc promoter-binding factor zf87/pur1 in transformed and nontransformed cell-lines.
Pyrc J; Logan T; Hall D
Int J Oncol; 1994 Nov; 5(5):1085-91. PubMed ID: 21559684
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ.
Izzo MW; Strachan GD; Stubbs MC; Hall DJ
J Biol Chem; 1999 Jul; 274(27):19498-506. PubMed ID: 10383467
[TBL] [Abstract][Full Text] [Related]
3. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.
Jordan-Sciutto KL; Dragich JM; Caltagarone J; Hall DJ; Bowser R
Biochemistry; 2000 Mar; 39(12):3206-15. PubMed ID: 10727212
[TBL] [Abstract][Full Text] [Related]
4. The ZF87/MAZ transcription factor functions as a growth suppressor in fibroblasts.
Stubbs MC; Min I; Izzo MW; Rallapalli R; Derfoul A; Hall DJ
Biochem Cell Biol; 2000; 78(4):477-85. PubMed ID: 11012087
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter.
Pyrc JJ; Moberg KH; Hall DJ
Biochemistry; 1992 Apr; 31(16):4102-10. PubMed ID: 1567856
[TBL] [Abstract][Full Text] [Related]
6. Physical characteristics of a factor related to the c-myc/insulin promoter binding protein ZF87/Pur-1.
Logan T; Pyrc J; Hall DJ
Biochem Biophys Res Commun; 1993 May; 192(3):1204-9. PubMed ID: 8507192
[TBL] [Abstract][Full Text] [Related]
7. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
[TBL] [Abstract][Full Text] [Related]
8. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.
Bossone SA; Asselin C; Patel AJ; Marcu KB
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7452-6. PubMed ID: 1502157
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1.
Hall DJ
Oncogene; 1990 Jan; 5(1):47-54. PubMed ID: 2181377
[TBL] [Abstract][Full Text] [Related]
10. Three distinct elements within the murine c-myc promoter are required for transcription.
Moberg KH; Logan TJ; Tyndall WA; Hall DJ
Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
[TBL] [Abstract][Full Text] [Related]
11. MAZ, a Myc-associated zinc finger protein, is essential for the ME1a1-mediated expression of the c-myc gene during neuroectodermal differentiation of P19 cells.
Komatsu M; Li HO; Tsutsui H; Itakura K; Matsumura M; Yokoyama KK
Oncogene; 1997 Sep; 15(10):1123-31. PubMed ID: 9294605
[TBL] [Abstract][Full Text] [Related]
12. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and gamma-interferon repress transcription from the c-myc P2 promoter by reducing E2F binding activity.
Carlberg AL; Moberg KH; Hall DJ
Int J Oncol; 1999 Jul; 15(1):121-6. PubMed ID: 10375604
[TBL] [Abstract][Full Text] [Related]
14. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
Majello B; De Luca P; Suske G; Lania L
Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
[TBL] [Abstract][Full Text] [Related]
15. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
16. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
17. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor.
Watanabe S; Ishida S; Koike K; Arai K
Mol Biol Cell; 1995 Jun; 6(6):627-36. PubMed ID: 7579683
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.
Thalmeier K; Synovzik H; Mertz R; Winnacker EL; Lipp M
Genes Dev; 1989 Apr; 3(4):527-36. PubMed ID: 2721961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
